Position in NBIX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$978,880
+$424,255 QoQ
Shares Held
5,808
+38.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#403
of 772 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $48,081,797 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
1,241,434 | $30,551,690 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
19,047 | $10,320,236 | |
| 3 | ZTS |
Zoetis Inc.
|
59,650 | $4,286,449 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
57,395 | $1,944,542 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
5,808 | $978,880 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $978,880 | 5,808 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $554,625 | 4,210 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $586,467 | 4,135 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $585,665 | 4,172 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $526,892 | 4,192 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $465,404 | 4,208 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||